Back to top

Tale of the Tape

Pacira Pharmaceuticals, Inc. (PCRX - Analyst Report) was a big mover last session, as the company saw its shares rise by over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $62.95 to $74.93 in the past one-month time frame.

This drug manufacturer has seen no estimate revision over the past 30 days while its Zacks Consensus Estimate has moved down over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Pacira Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the technology sector include Bio-Path Holdings, Inc. (BPTH - Snapshot Report) , Cell Therapeutics, Inc. (CTIC - Snapshot Report) and Grifols, S.A. (GRFS - Snapshot Report) . All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>